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The RAD52 gene is essential for homologous recombination in the yeast Saccharomyces cerevisiae. RAD52 is
the archetype in an epistasis group of genes essential for DNA damage repair. By catalyzing the replacement
of replication protein A with Rad51 on single-stranded DNA, Rad52 likely promotes strand invasion of a
double-stranded DNA molecule by single-stranded DNA. Although the sequence and in vitro functions of
mammalian RAD52 are conserved with those of yeast, one difference is the presence of introns and consequent
splicing of the mammalian RAD52 pre-mRNA. We identified two novel splice variants from the RAD52 gene
that are expressed in adult mouse tissues. Expression of these splice variants in tissue culture cells elevates the
frequency of recombination that uses a sister chromatid template. To characterize this dominant phenotype
further, the RAD52 gene from the yeast Saccharomyces cerevisiae was truncated to model the mammalian splice
variants. The same dominant sister chromatid recombination phenotype seen in mammalian cells was also
observed in yeast. Furthermore, repair from a homologous chromatid is reduced in yeast, implying that the
choice of alternative repair pathways may be controlled by these variants. In addition, a dominant DNA repair
defect induced by one of the variants in yeast is suppressed by overexpression of RAD51, suggesting that the
Rad51-Rad52 interaction is impaired.
Homology-directed repair (HDR) allows cells to repair
DNA double-strand breaks (DSBs) in an error-free way and is
a key mechanism for maintaining genome integrity in all eu-
karyotes (11, 48, 52). RAD52 is an essential gene for HDR in
the yeast Saccharomyces cerevisiae (20, 30, 46). Identified as
one member of an epistasis group of radiation-sensitive yeast
mutants, rad52 strains are defective in HDR, the major DSB
repair pathway in yeast. RAD52 is largely conserved through-
out eukaryotes, and both the human and yeast Rad52 proteins
stimulate the replacement of replication protein A with Rad51
on single-stranded DNA (4, 29, 39, 45). Additionally, Rad52
promotes DNA annealing and strand exchange between a
DNA duplex and complementary single-stranded DNA (14,
21, 27). Three-dimensional structures of the N terminus of
human RAD52 (hRAD52) reveal a multimeric ring containing
a positively charged surface groove that has been suggested to
bind single-stranded DNA (15, 40). Relative to the N terminus
of Rad52, the C terminus is poorly conserved between ho-
mologs. The C terminus of Rad52 is essential for its interaction
with Rad51, a bacterial RecA homolog (26, 37). Consistent
with its ability to bind both itself and other DNA repair pro-
teins, Rad52 forms discrete nuclear foci both spontaneously
and in response to DNA damage, and these DNA repair cen-
ters are the sites of DSB repair (23–25, 32).
Although yeast RAD52 plays a critical role in HDR, surpris-
ingly, RAD52 knockout mice are resistant to DNA damage
(35). However, it is likely that mammalian RAD52 is important
for DNA repair, as its activities are conserved with yeast
Rad52; in addition, HDR in chicken cells requires RAD52 (5,
42). Furthermore, RAD52 null mice have a defect in gene
targeting (35), and loss of RAD52 rescues the tumorigenic
phenotype of ATM-deficient mice (50). An alternative expla-
nation for the phenotype of the RAD52 knockout mice is that
the functions of yeast Rad52 are redundant in higher eu-
karyotes. Mammals have a number of other genes, such as
XRCC3 and BRCA2, that may encode complementary func-
tions with yeast RAD52 (9, 10, 38).
Another difference between the mammalian and yeast
RAD52 genes is the presence of introns. The open reading
frames (ORFs) of both human and mouse RAD52 are divided
into 12 exons whose positions relative to the RAD52 open
reading frame are conserved. Splice variants of hRAD52 have
been isolated from cDNA libraries derived from both brain
and testes tissues, and the encoded protein variants were found
to bind to DNA but not to wild-type hRAD52 in vitro (16).
Here we report the isolation of two new splice variants from
adult mouse tissues. We show that these variant transcripts act
as dominant alleles in both mammalian cells and the yeast S.
cerevisiae. In both mammalian cells and yeast, the variants
perturb HDR, specifically by elevating the frequency of sister
chromosome repair. In yeast, both variants also decrease the
frequency of repair from a homologous chromatid. Further-
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more, for one variant in yeast, the defect in DNA repair is
suppressed by overexpression of RAD51. These data show that
the splice variants have the potential to alter the ratio of repair
from the homologous to the sister chromosome, possibly by
impairing the interaction of Rad52 with Rad51.
MATERIALS AND METHODS
RNA isolation and reverse transcription-PCR (RT-PCR). Whole-tissue sam-
ples were homogenized first by passing approximately 15 mg tissue several times
through a 27-gauge needle in RNAlater buffer (Ambion) and then through a
QIAshredder column (QIAGEN). RNA was purified from the resulting suspen-
sion without delay using the RNAeasy column purification system (QIAGEN).
Three to 5 g of RNA was used for cDNA synthesis using random hexamer
primers, thus ensuring that the cDNA represents all the transcripts present in the
tissue. Either the Superscript first-strand synthesis system for RT-PCR (Invitro-
gen) or first-strand cDNA synthesis kit for RT-PCR (Roche) was used for this
cDNA synthesis. Approximately 10% of the resulting cDNA was used as a
template for PCR using gene specific primers.
As a control for cDNA yield, primers were designed to amplify a 209-bp
product spanning exons 5 to 8 from a spliced transcript of the murine glyceral-
dehyde 3-phoshate dehydrogenase gene (GAPDH). Each RT reaction includes a
matched control that omits the reverse transcriptase enzyme to confirm that the
subsequent PCR products are derived from cDNA and not from DNA contam-
ination. GAPDH primers used for PCR were 5 TGGAGCCAAAGCGGTC
ATCA and 5 GTGGCAGTGATGGCATGGAC. RAD52 exon 1 to 7 primers
were 5 AGTCTCCATTCCTTCTGCGAG and 5 ACAGTTTCCAAGTGCAT
TCCC. RAD52 exon 6 to 11 primers were 5 GGAAGGAGGCTGTGACT
GATG and 5 GGTTCTGCTCTACACAAGGGC (all oligonucleotides were
obtained from Sigma-Genosys). All PCR amplifications used the following pro-
tocol: 95°C for 5 min, followed by 30 cycles of 94°C for 30 s, 55°C for 30 s, and
72°C for 1 min. The resulting PCR products were separated by Tris-borate-
EDTA (TBE)-agarose gel electrophoresis, and the gels were blotted overnight
onto Hybond-N membrane (Amersham Biosciences). The DNA was cross-
linked to the Hybond blots using UV irradiation (120 mJ/cm2 using a Stratal-
inker; Stratagene). The blots were then prehybridized with 100 g/ml salmon
testes DNA in PerfectHyb Plus buffer (Sigma) at 48°C for 1 to 2 h. To synthesize
radiolabeled oligonucleotide probes, 1,000 U of T4 polynucleotide kinase
(Roche) was used to label 40 ng (6 pmol) oligonucleotide with 25 Ci (8
pmol) [-32P]ATP (PerkinElmer Life Sciences). For GAPDH blots, the primer 5
TCCTGCACCAACTGCTTA was labeled. For RAD52 exons 1 to 7, 5 GGAA
GGAGGCTGTGACTGATG was labeled, and for RAD52 exons 6 to 11, both 5
ACAGTTTCCAAGTGCATTCCC and 5 CAGCCTCAGAACTCCTCCAGG
were labeled. The oligonucleotide probes were hybridized with the blots over-
night at 48°C. Blots were washed several times in 4 SSC (1 SSC is 0.15 M
NaCl plus 0.015 M sodium citrate), 0.1% sodium dodecyl sulfate at room tem-
perature before autoradiograph images were obtained.
To sequence the RT-PCR products, the samples were reamplified with an
additional 30 cycles of PCR, and the products were separated by TBE-agarose
gel electrophoresis. The bands corresponding to novel transcripts were cut from
the gels, and the DNA was purified using QIAquick columns (QIAGEN).
Polyribosome preparation. Approximately 107 mouse 3T3 cells were washed
once with ice-cold phosphate-buffered saline (PBS) and then scraped from the
dish in 200 l ice-cold, diethyl pyrocarbonate (DEPC)-treated lysis buffer (10
mM HEPES, 300 mM KCl, 5 mM MgCl2, 0.5% NP-40). The lysate was passed
three times through a 27-gauge needle, and the nuclei were removed by centrif-
ugation (13,000 rpm) for 5 min at 4°C. The supernatant was applied directly to
the top of a 10-ml, 15 to 45% DEPC-treated sucrose gradient (prepared in 10
mM HEPES, 300 mM KCl, 5 mM MgCl2) and centrifuged at 38,000 rpm for 90
min at 3°C. Fractions were collected from the bottom of the gradient, monitored
with UV absorbance (280 nm), and placed into an equal volume of RNAlater
(QIAGEN). RNA was purified from these fractions using RNAeasy reagents
(QIAGEN), and RT-PCR was performed as described above.
Mammalian cell culture transfections. A plasmid, pRAD52(pWJ1456), con-
taining the mouse RAD52 gene under the control of a cytomegalovirus immedi-
ate-early promoter was based on pIRES-EGFP. Briefly, the RAD52 sequence
obtained from mouse embryonic cDNA libraries was subcloned as a 1.6-kb
EcoRI DNA fragment from pWJ669 (3) into the EcoRI cloning site of pIRES-
EGFP (BD Biosciences, Clontech). Subsequently, the enhanced green fluores-
cent protein (EGFP) gene was removed by deletion of a 1-kb XmnI-NotI re-
striction endonuclease fragment from this and all other pIRES-EGFP-derived
vectors used in this study. The two variant plasmids, pRAD52exon4(pWJ1457)
and pRAD52intron8(pWJ1458), were created using the Quickchange mutat-
genesis kit (Stratagene) to alter the RAD52 sequence. Briefly, pRAD52exon4 is
identical to pRAD52, except for the deletion of 94 bp corresponding to RAD52
exon 4. pRAD52intron8 is identical to pRAD52, except for the inclusion of 139
bp of mouse RAD52 intron 8 (derived from the RT-PCR of mouse tissues
described above). pCMV(pWJ1459), lacking the RAD52 gene, is a control vector.
Chinese hamster ovary cells (CHO) cells were used to assay HDR. These cells
contain a direct repeat of the GFP gene in which one repeat is full length but is
inactivated by the inclusion of an I-SceI endonuclease target site. The second
repeat lacks both the 5 and 3 ends of the gene. After cleavage with the I-SceI
endonuclease, the resulting DSB can be repaired by gene replacement from the
second GFP repeat either from the same or from a sister chromosome, resulting
in a functional GFP allele (see Fig. 5A). The efficiency of repair is scored by
fluorescence-activated cell sorting (FACS). The plasmid encoding the homing
endonuclease I-SceI (pCAGGS-I-SceI) as well as the CHO and CHO-XRCC3/
cell lines containing the DR-GFP reporter were kind gifts from Maria Jasin and
Jeremy Stark, and their use has been described elsewhere (31). Cells were grown
in serum-plus medium (Dulbecco’s modified Eagle medium containing 10%
newborn bovine serum, 4.5 g/liter glutamine, 4.5 g/liter glucose, 110 mg/liter
sodium pyruvate, and 100 U/ml penicillin-streptomycin; all from Invitrogen-
GibcoBRL) at 37°C, 6% CO2. Cells were harvested from culture dishes after 2
to 10 min of incubation with trypsin-EDTA (Invitrogen) and then washed once
in PBS. Cells (2  105) were plated on 60-mm tissue culture dishes and grown
overnight in serum-plus medium. The following day the cells were transfected in
OPTIMEM medium (Invitrogen) with 4 g/dish plasmid DNA (2 g of pI-SceI
and 2 g of experimental plasmid as indicated), using 4 l/dish lipofectin (In-
vitrogen) following the manufacturer’s instructions (this DNA:lipofectin ratio
was determined to be optimal for expression of GFP from the pIRES-GFP
vector). Transfection was carried out for 5 h, after which the medium was
replaced with serum-plus medium. After 48 h, the cells were collected using
trypsin-EDTA, washed twice in PBS, and resuspended in 200 to 600 l PBS.
FACS analysis was performed on the cells as previously described (49). Expres-
sion levels of I-SceI from the pI-SceI vector were assumed to be equivalent in
each case. The expression of the mammalian variants was assessed by a parallel
experiment in which CHO cells were transfected with plasmids equivalent to
those described above but including the internal ribosomal entry site (IRES)-
GFP sequence. This GFP sequence produces fluorescence signal in all cells
that successfully take up and express the plasmid vector. FACS analysis of the
resulting transfections allowed the measurement of the proportion of CHO
cells transfected (GFP). For each of the four vectors (pIRES-GFP, pRAD52-
IRES-GFP, pRAD52exon4-IRES-GFP, and pRAD52intron8-IRES-GFP)
the number of cells transfected was equivalent (Fig. SB in the supplemental
material).
Mammalian cell synchronization. To obtain a synchronous culture of mouse
3T3 cells, the cells were grown to near confluence in 150-cm2 tissue culture flasks
and then arrested with 400 ng/ml (1.3 M) nocodazole for 6 h. The mitotic cells
were then collected by mitotic shake-off, which involves mechanical shaking of
the flasks for 5 min. The pooled mitotic cells were collected by centrifugation,
washed twice in nocodazole-free media, and then grown in nocodazole-free
media. Cells were plated in 60-cm2 dishes and harvested at various time points
using trypsin. One aliquot was fixed in 100% ethanol at20°C for at least 30 min.
These fixed cells were then stained in PBS with 50 g/ml propidium iodide and
200 g/ml RNase A (Sigma) at 4°C for at least 30 min prior to FACS analysis.
A second aliquot was placed directly into RLT buffer (QIAGEN) and stored at
80°C for RNA preparation as described above.
Yeast strains and methods. Standard genetic methods were used for the
growth and manipulation of yeast (36). The yeast strains used in this study are
listed in Table 1. The strains encoding Rad52 tagged with yellow fluorescent
protein (YFP) and cyan fluorescent protein (CFP) have been reported previously
(23). We modified W3749-14C (Rad52-YFP) using our previously published
allele replacement method (8). Briefly, PCR primers were designed to generate
targeting fragments that eliminate either the 3 1,281 bp of RAD52 for rad5277-
YFP or the 3 660 bp of RAD52 for rad52284. The final five amino acids of yeast
Rad52 encoded by rad5277 and rad52284 are -FGTSR and -DTDLK, respec-
tively. The two resulting RAD52 deletion strains (W5001-9C and W5002-5A)
maintain the truncated yeast RAD52 ORF in frame with the downstream YFP
gene. The sensitivity of yeast strains to -irradiation was determined by growing
strains in YPD to log phase and then plating on YPD plates and irradiating them
using a Gammacell-220 60Co irradiator (Atomic Energy, Ottawa, Canada). The
proportion of S/G2-phase cells in log-phase culture containing Rad52-YFP and
-CFP foci were determined using fluorescence microscopy as previously de-
scribed (23, 25). The fluorescence of tagged Rad52 protein in individual cells was
measured by reconstructing cells in three dimensions from fluorescent images
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and quantifying the relative fluorescence using Volocity software (Improvision,
Lexington, MA).
The strains encoding the two heteroalleles of ADE2 were a kind gift from
Lorraine Symington, and their use has been described elsewhere (12). The
ade2-n allele contains a fill-in mutation of the 3 NdeI restriction endonuclease
target site of the yeast ADE2 gene, and the ade2-a allele contains a fill-in
mutation of the 5 AatII site (2). The frequency of heteroallelic recombination
was measured for at least nine independent isolates of each diploid strain. Cells
were grown overnight in synthetic complete (SC) medium and washed once in
H2O before being briefly sonicated. Serial 10-fold dilutions were plated both on
SC medium and in duplicate on adenine-deficient medium. Colonies were
counted after 48 h, and the method of Lea and Coulson was used to estimate
“m,” the mean number of recombinants per culture (22).
The strains used for the direct-repeat assay contain two defective LEU2 alleles
separated by a URA gene and were derived from previously published strain
W1470 (41). Strains for direct-repeat recombination were treated in the same
way as those for heteroallelic recombination, except that the cells were plated on
SC and, in duplicate, on leucine-deficient medium. This direct-repeat recombi-
nation assay also allows us to measure the frequency of single-strand annealing
(SSA) events, which are scored by the loss of a URA3 marker (pop-out), which
is placed between the two repeated leu2 alleles. As the leu2 direct repeat is
present as a diploid, LEU2 cells resulting from SSA events will be ura3/
URA3, compared to URA3/URA3 for replacement events. Plating the
LEU2 colonies on medium containing 5-fluoroorotic acid (5-FOA), which se-
lects against URA3, allowed us to differentiate the URA3 genotype. The colonies
that were ura3/URA3, when replica plated to 5-FOA, produced small papillae,
indicative of their ability to lose the single URA3 gene. In contrast, the URA3/
URA3 colonies failed to grow at all on 5-FOA. Sporulating a selection of each
class of LEU colonies and testing the ability of the haploid spores to grow on
uracil-deficient medium confirmed their URA3 genotypes (data not shown). This
allowed us to estimate the proportion of LEU recombinants resulting in pop-
out events compared to replacement events (illustrated in Fig. 6A).
RESULTS
Identification of mouse splice variants. Preliminary data
derived from our sequencing of the mouse RAD52 gene (un-
published observations) and from RT-PCR from an array of
different mouse tissues (see Fig. SA in the supplemental ma-
terial) suggested that at least two splice variants of mouse
RAD52 are commonly expressed. To investigate these findings
further, tissue samples of lung and liver were dissected from
two C57BL/6J mice and used for RT-PCR. A series of over-
lapping PCRs were performed covering the length of the
mouse RAD52 cDNA, as illustrated in Fig. 1A. The murine
RAD52 gene contains 12 exons. Three PCRs amplify cDNA
from exons 1 to 7, 6 to 11, and 10 to 12. These PCRs were
designed to detect most alterations in splicing that are pre-
FIG. 1. (A) Twelve exons of the mouse RAD52 gene are shown as
numbered boxes approximately to scale; the position of each intron is
shown as a short gap, but the introns are not shown to scale. A gray box
above the gene indicates the open reading frame of the full-length
RAD52 peptide, which extends from the start of exon 2 to the start of
exon 12. The three primer pairs for RT-PCR across the RAD52 tran-
script are indicated by converging arrows (exons 1 to 7, 6 to 11, and 10
to 12). (B, C, and D) Autoradiographs of the blots derived from the
mouse RT-PCR are shown. A limited number of PCR cycles (30) was
used, followed by genomic blotting, to ensure that all products de-
tected are specific for the mouse RAD52 gene. Each autoradiograph
has 18 lanes, 8 with samples derived from the lung and 8 with samples
derived from liver, plus 2 control lanes (H2O, no template added). Two
separate tissue samples were prepared from each of the two mice, and
in each case the cDNA was prepared with and without reverse tran-
scriptase (rt, indicated by  or  above the lanes) to ensure that all
products are derived from RNA. The sizes of the bands are indicated
based upon the position of size markers from the original TBE-agarose
gels. The top autoradiograph (B) shows the results using primers
designed to amplify RAD52 exons 1 to 7, and the middle autoradio-
graph (C) shows the results using primers designed to amplify RAD52
exons 6 to 11. The bottom autoradiograph (D) shows the results using
primers designed to amplify GAPDH exons 5 to 8, which serves as a
control for RNA preparation.
TABLE 1. Yeast strains used in this study
Straina Relevant genotype
W5933 ..............................rad52::HIS5/RAD52-YFP
W5934 ..............................rad52::HIS5/rad5277-YFP
W5935 ..............................rad52::HIS5/rad52284-YFP
W5936 ..............................rad52::HIS5/rad52::HIS5
W5937 ..............................RAD52-CFP/RAD52-YFP
W5938 ..............................RAD52-CFP/rad5277-YFP
W5939 ..............................RAD52-CFP/rad52284-YFP
W5957 ..............................ade2-n/ade2-a RAD52/RAD52
W5958 ..............................ade2-n/ade2-a RAD52/rad52::HIS5
W5959 ..............................ade2-n/ade2-a RAD52/rad5277-YFP
W5960 ..............................ade2-n/ade2-a RAD52/rad52284-YFP
W5977 ..............................leu2EcoRI::URA::leu2BstEII/leu2EcoRI::
URA::leu2BstEII RAD52/RAD52
W5978 ..............................leu2EcoRI::URA::leu2BstEII/leu2EcoRI::
URA::leu2BstEII RAD52/rad52::HIS5
W5979 ..............................leu2EcoRI::URA::leu2BstEII/leu2EcoRI::
URA::leu2BstEII RAD52/rad5277-YFP
W5980 ..............................leu2EcoRI::URA::leu2BstEII/leu2EcoRI::
URA::leu2BstEII RAD52/rad52284-YFP
a All strains in this study are RAD5 derivatives of W303 (47, 54). In addition
to the genotype listed above, all strains are MATa/MAT	 lys2/LYS2 trp1-1/TRP1
and homozygous for ADE2 can1-100 ura3-1 his3-11,15 leu2-3,112, except where
indicated. Strains W5933 through W5939 are also homozygous for bar1::LEU2;
the other strains are BAR1. The rad52::HIS5 allele is rad52.
3754 THORPE ET AL. MOL. CELL. BIOL.
dicted from earlier studies (Fig. SA), such as the removal of
exon sequence or the inclusion of intron sequences. Gels were
blotted and probed with radiolabeled oligonucleotides to en-
sure that the RT-PCR products are specific for the RAD52
gene. Using a relatively low number of PCR cycles and subse-
quent gel blotting also allows a semiquantitative assessment of
the template RNA, as the RT-PCRs have not saturated.
We observed two variant products consistent with alterna-
tive splicing in addition to the expected RAD52 transcript
products corresponding to the annotated RAD52 sequence
(Fig. 1B and C). The expected product from exons 1 to 7 is 591
bp; however, a smaller, 500-bp product was also identified
(Fig. 1B). As depicted in Fig. 1C, products amplified from
exons 6 to 11 give rise to a larger product of 750 to 800 bp in
addition to the expected 631-bp product. No alternatively
spliced products were observed from exons 10 to 12 (data not
shown). Figure 1D shows the GAPDH control.
Both of these variant products are predicted to encode trun-
cated RAD52 peptides (Fig. 2). DNA sequencing of the novel
products revealed the alternative splicing. The small-variant
product from exons 1 to 7 corresponds to a deletion of RAD52
exon 4 (RAD52exon4). The sequence of the large-variant
product from exons 6 to 11 corresponds to an inclusion of the
intron 8 sequence (RAD52intron8). RAD52exon4 is pre-
dicted to encode amino acids 1 to 63 of RAD52 and 17 “out of
frame” amino acids from exon 5. RAD52intron8 is predicted
to encode amino acids 1 to 248 of RAD52, and 42 “novel”
amino acids are encoded by intron 8.
Splice variants are associated with polyribosomes. The
RAD52 splice variants are predicted to encode C-terminal
truncations of the RAD52 protein. Since degradation products
of normal RAD52 could confound the results of a protein blot
and specific antibodies to the N terminus of murine RAD52
are not available, we had to rely on additional evidence to
determine if the splice variants are being translated. In partic-
ular, we searched for these splice-variant mRNAs on polyri-
bosomes, the mRNA-ribosome complexes that are active in
translation. Polyribosomes were purified from mouse 3T3 cells
and fractionated based on size using 15% to 45% sucrose
density gradients, which isolate polyribosomes containing four
to six ribosomes in the middle of the gradient (the UV absor-
bance profile at 280 nm is provided in Fig. SC in the supple-
mental material). These fractions were then analyzed using the
same splice-specific RT-PCR strategy used to originally iden-
tify the variants (described above) to screen for RAD52exon4
and RAD52intron8. The normal RAD52 transcript and both of
the splice variants are associated with polyribosomes (Fig. 3),
indicating that the normal and variant RAD52 transcripts are
being actively translated in these mouse cells.
Splice variants are expressed uniformly throughout the cell
cycle. Since Rad52 is thought to act primarily in S and G2 and
to be inactive in G1, it is of interest to assay the expression of
the splice variants throughout the cell cycle. Therefore, the
expression of the variants in synchronized mouse 3T3 cells was
examined as described in Materials and Methods. For each
time point, an aliquot was stained with propidium iodide and
used to analyze DNA content by FACS analysis, and a second
aliquot was used for RNA preparation. RT-PCR was per-
FIG. 2. RAD52 peptide is aligned with the predicted product of the two variant transcripts, RAD52exon4 and RAD52intron8. The
RAD52exon4 sequence includes the first 63 amino acids of RAD52 followed by 18 “out of frame” amino acids (underlined and italicized),
encoded by exon 5. The RAD52intron8 sequence includes the first 248 amino acids of RAD52, followed by 42 amino acids encoded by intron
8 (underlined and italicized).
FIG. 3. Two autoradiographs are shown of blots of RT-PCRs spe-
cific for RAD52exon4 (primers amplify exons 1 to 7, top) and
RAD52intron8 (primers amplify exons 6 to 11, bottom). Each blot
contains 10 lanes, representing the 10 fractions from the sucrose gra-
dient, 1 to 10 in the order they came off the gradient. The lane to the
right (1) represents products obtained from the bottom of the gradient;
this may include some residual nuclei and high-molecular-mass com-
plexes. The lanes to the left (8 to 10) contain low-molecular-mass
complexes including free RNA molecules. Lanes 2 to 7 represent
samples obtained from the polyribosome-containing fraction of the
gradient. The UV absorbance profile of the polyribosome gradient is
shown separately in Fig. SC of the supplemental material.
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formed on the RNA as described above. Figure 4A shows the
FACS profile of the cells following release from nocodazole
arrest, and Fig. 4B shows the results of RT-PCR. We could
detect no significant difference in the ratio of splice variant to
normal transcript for either RAD52exon4 or RAD52intron8
at any stage in the cell cycle. The RT-PCR products appear the
same as asynchronously dividing cells (as in Fig. 3).
Splice variants modeled in mammalian cell culture cause
dominant recombination effects. To test whether the mamma-
lian splice variants cause functional changes in HDR, an es-
tablished assay for gene repair in Chinese hamster ovary
(CHO) cells was used. These cells contain the HDR reporter
system outlined in Materials and Methods (also see Fig. 5A).
Briefly, an I-SceI-induced DSB, within a nonfunctional GFP
gene, can be repaired by gene conversion from a neighboring
sequence to restore a functional GFP open reading frame.
CHO cells were transfected with vectors expressing the normal
RAD52 cDNA, the two variant cDNAs, RAD52exon4 and
RAD52intron8, or the control (summarized in Fig. 5B). Ex-
pression of RAD52 has no significant effect on HDR in this
assay (Fig. 5C), similar to the expression of RAD52 in a cell
line mutated in rad52 (43). Interestingly, expression of either
of the splice variant constructs elevates the frequency of repair
compared to that of full-length RAD52 (Fig. 5C).
Since there is evidence from chicken cells to suggest that
RAD52 acts in parallel with XRCC3 in DNA damage repair
(10), the mammalian HDR experiments were repeated with a
CHO cell line that lacks XRCC3 (CHO-XRCC3/) to see how
the splice variants act in this mutant. Consistent with previous
observations (31), the overall frequency of HDR in this cell
line is more than 10-fold lower than in wild-type cells. How-
ever, overexpression of the RAD52 splice variants did not
change the levels of HDR (Fig. 5D).
Finally, we attempted to knock down the level of the
RAD52intron8 variant in CHO cells by designing small inter-
fering RNA against the hamster intron 8 sequence. However,
transfection of this small interfering RNA had no detectable
effect on the level of the intron 8 variant (as judged by RT-
PCR) or the frequency of recombination of the GFP targets in
the presence of I-SceI (data not shown).
Splice variants modeled in yeast cause dominant recombi-
nation effects. The ability to conduct functional recombination
studies in mammalian cells is currently hindered by the limited
number of functional assays that distinguish between recom-
bination products; for example, if it is difficult to differentiate
repair from a homolog as opposed to a sister chromosome.
Consequently, we employed the budding yeast Saccharomyces
cerevisiae to assay for dominant-negative behavior of the splice
variants. To mimic the C-terminal truncations that are pre-
dicted to be encoded by the two mouse splice variants,
RAD52exon4 and RAD52intron8, the RAD52-YFP (encod-
ing Rad52 fused to yellow fluorescent protein) gene from Sac-
charomyces cerevisiae (23) was modified at the yeast chromo-
somal locus. The RAD52exon4 and RAD52intron8 mouse
splice variants were recreated in the yeast RAD52-YFP gene as
rad5277 and rad52284, respectively (the numbers corre-
spond to the final amino acid in the deleted Rad52 sequences).
It is important to note that the mouse sequences were not
transferred into yeast; rather, the yeast sequence was used to
model the mouse transcripts by creating truncations of the
endogenous yeast RAD52 gene. We refer to these two yeast
alleles as “splice variant equivalents.”
As the mouse variants showed increased HDR when ex-
pressed in mammalian cells (Fig. 5), a similar repair assay was
performed in yeast. Recombination between direct repeats was
assayed using a reporter system containing two defective al-
leles of LEU2 (leu2EcoRI and leu2BstEII) (Fig. 6A). Similar
to the HDR assay used in CHO cells, the leu2 direct-repeat
reporter assays primarily intrachromatid and sister chromatid
recombination (17, 41). Commonly, two kinds of LEU2 prod-
ucts result: replacements, where one of the leu2 alleles is re-
paired without loss of the intervening URA3 sequence; or pop-
out events, where the URA3 is lost by deletion of the sequence
between the two LEU2 alleles (Fig. 6A). As described in Ma-
terials and Methods, these two events are distinguished by a
FIG. 4. (A) The FACS profile shows cells stained with propidium
iodide at seven different time points after release from nocodazole
arrest and mitotic shake off. At time zero the cells are arrested in G2,
by 6 h most of the cells have entered G1, and by 12 h many of the cells
have entered S phase. The percentages for 2n and 4n indicate the per-
centage of the cell population that fall within the limits of the black bars
shown above the FACS profile. (B) Autoradiographs (as in Fig. 1B, C,
and D) for the RT-PCR products used to identify RAD52exon4 (top),
RAD52intron8 (middle), and GAPDH control (bottom) from the time
points shown above.
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simple replica-plating assay. Since the mouse splice variants
detected in our screen are expressed together with the normal
transcript (Fig. 1B and C, 3, and 4B), we next created diploid
yeast strains that contain a full-length RAD52 allele in addition
to a splice variant-equivalent allele to screen for dominant
effects on direct-repeat recombination. Both of the RAD52
splice variant equivalents elevate the frequency of LEU2 re-
combinants (Fig. 6B). While the effects upon recombination
FIG. 5. (A) Schematic representation of the reporter system devel-
oped by Pierce and colleagues (31). puro, puromycin-N-acetyltrans-
ferase gene. A double-strand break can be introduced into this re-
porter using the I-SceI endonuclease, and subsequent HDR from a
downstream GFP fragment enables the repair of a functional GFP
sequence. These HDR events can be scored by FACS analysis. Four
expression vectors were created from a derivative of the pIRES-EGFP
vector (Clontech) as described in Materials and Methods (B). The four
vectors include the empty vector control pCMV, full-length mouse
RAD52 (pRAD52), or the two splice variants, pRAD52exon4 and
pRAD52intron8, as indicated in panel B. (C) The frequency of HDR
events in CHO cells (scored as % GFP cells using FACS analysis) is
shown. For each transfection the plasmid is indicated below. In addi-
tion, each transfection included an I-SceI-expressing plasmid; the
mean of four experiments is indicated (
standard deviation). Analysis
of variance indicates significant differences between the groups (data
not shown). Both of the variant plasmids (pRAD52exon4 and
pRAD52intron8) have a higher frequency of HDR events than the
wild-type RAD52 plasmid (one-tailed t test, P 4.9 105 and P 7.5
 104, respectively). A CHO cell line, deficient in XRCC3, was also
tested in the same way (D). The difference between the wild-type
RAD52 plasmid and the pRAD52exon4 plasmid is not significant
(one-tailed t test, P  0.094). The difference between the wild-type
RAD52 plasmid and the pRAD52intron8 plasmid is significant (one-
tailed t test, P  0.044).
FIG. 6. (A) Frequency of direct-repeat recombination was assayed
as indicated. Two leu2 alleles are schematically represented (top), with
dark triangles indicating the two mutations that inactivate the gene.
Recombination between the two repeated sequences can restore a
functional LEU2 gene, and two possible LEU recombinant structures
are shown. First, a replacement event restores the wild-type LEU2
sequence to one of the leu2 alleles (e.g., the upstream sequence is
restored). Second, a pop-out event is shown where single-strand an-
nealing recombines the two repeated leu2 alleles, leading to loss of the
URA3 gene and both mutations within LEU2. Other possible events
such as triplications are discussed elsewhere (41). (B) The median leu2
recombination frequency m, as defined by Lea and Coulson (22), is
shown, where the error bars indicate 
 standard deviation of m. The
wild-type RAD52 allele is abbreviated wt. Both variant alleles
(rad5277/null and rad52284/null) have a higher frequency of direct-
repeat recombination than the heterozygous wild-type strain (wt/null),
(one-tailed t tests, P  8.5  103 and 4.4  106, respectively). The
frequency of recombination in the heterozygous wild-type strain (wt/
null) versus a wild-type diploid strain (wt/wt) is not significantly dif-
ferent (one-tailed t test, P  0.41). Similarly, the recombination fre-
quency in the rad5277/null strain is not significantly different from
that of the rad52284/null strain (one-tailed t test, P  0.089).
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are modest, they are significantly different from those of a
heterozygous strain (one-tailed t tests, P 8.5 103 and 4.4 
106 for rad5277 and rad52284, respectively). These effects
are similar to those seen in mammalian cell culture (Fig. 5).
Interestingly, in yeast, the rad5277 allele increases replace-
ment events, while the rad52284 allele increases the fre-
quency of URA3 pop-outs (Table 2).
The yeast system has the advantage that the variants are
easily assayed for effects on other types of DNA repair. There-
fore, we analyzed the splice variant equivalents for their effects
on heteroallelic recombination, focus formation, and DNA
damage sensitivity. First, spontaneous heteroallelic recombina-
tion was assayed in diploid yeast with two defective ade2 het-
eroalleles (ade2-n and ade2-a). Recombination between these
alleles, which reside at each end of the ADE2 gene on homol-
ogous chromatids, restores a functional ADE2 gene (Fig. 7A).
Surprisingly, in contrast to the elevated frequency of direct-
repeat recombination seen in both mammalian cells (Fig. 5)
and yeast (Fig. 6B), both of the splice variant equivalents
lowered the frequency of yeast heteroallelic recombination
(Fig. 7B). These disparate phenotypes suggest that the variants
may be promoting sister chromatid repair while at the same
time suppressing repair from a homologous chromosome.
In yeast, Rad52 and other DNA repair proteins form distinct
nuclear foci at the sites of double-strand break repair (23–25).
These DNA repair centers appear predominantly in S and G2
phases of the cell cycle. Altered levels of foci within yeast
strains are indicative of DNA repair deficiencies (25). Next, the
formation of foci in the splice variant equivalent strains was
measured using fluorescence microscopy. Both splice variant
equivalents fail to form spontaneous foci in a haploid strain
(data not shown). Diploid strains containing the splice variant
equivalents tagged with YFP and wild-type Rad52 tagged with
CFP (cyan fluorescent protein) were assayed for focus forma-
tion. Interestingly, in these strains, the Rad52284-YFP protein
forms foci that also contain wild-type Rad52-CFP (Fig. 8A), sug-
gesting that Rad52284-YFP and wild-type Rad52 are incorpo-
rated into the same DNA repair complex. The same phenotype is
not observed for Rad5277-YFP. Additionally, both splice vari-
ant equivalents elevate the proportion of S/G2 cells that contain
spontaneous wild-type Rad52 foci, indicative of either increased
DNA damage or an altered DNA repair activity within these cells
(Fig. 8B).
Unlike in mammalian cells, RAD52 is essential for HDR in
yeast, and furthermore HDR is its major DSB repair pathway.
Therefore, DNA damage sensitivity is a standard assay for the
function of yeast Rad52. First, we estimated protein levels in
diploid strains containing differentially tagged Rad52 peptides
(CFP and YFP) to ensure that the splice variant equivalent
alleles do not alter the expression of RAD52 from either the
wild-type or mutant allele. Table 3 shows the amount of the
YFP and CFP detected in the nucleus of the different strains,
and there is no significant difference between the two mutant
strains and the wild-type diploid. Next, the repair capacity of
the splice variant equivalent strains was assayed by measuring
viability with increasing doses of -irradiation. Both rad5277
and rad52284 are as sensitive to -irradiation as rad52 null
strains, either as haploid strains (data not shown) or as het-
erozygous diploids containing a null allele (Fig. 9A, first four
rows). The diploid strains containing both a mutant and wild-
type RAD52 allele were tested for sensitivity to -irradiation,
and rad5277 (Fig. 9A, sixth row) is as sensitive as a wild
type/null (Fig. 9A, top row). In contrast, rad52284 confers a
dominant-negative phenotype for -irradiation sensitivity (Fig.
9A, last row, indicated by the white arrow).
FIG. 7. (A) Heteroallelic recombination is measured using two ade2
alleles as shown schematically. The dark triangles indicate the two muta-
tions that inactivate the gene: ade2-a is a fill-in mutation of the AatII site
in the 5 end of the gene, and ade2-n is a fill-in mutation of the NdeI site
in the 3 end of the gene (12). Recombination between the two homologs
restores a functional ADE2 gene, as indicated. The gene conversion event
depicted has lost the 3 ade2-n mutation, leading to restoration of a
functional ADE2 gene. The frequency of heteroallelic recombination is
calculated using the methods described by Lea and Coulson (22). (B) The
median ade2 recombination frequency m as defined by Lea and Coulson;
the error bars indicate 
 standard deviation of m. The wild-type allele is
abbreviated wt. Both variant alleles (rad5277/null and rad52284/null)
have a lower frequency of heteroallelic recombination than the heterozy-
gous wild-type strain (wt/null) (one-tailed t tests, P  104). The fre-
quency of recombination in the diploid wild-type strain (wt/wt) does not
differ significantly from the heterozygous wild-type strain (wt/null) (two-
tailed t test, P  0.87). The rad5277/null strain has a significantly lower
frequency of recombination than the rad52284/null strain (one-tailed t
test, P  2  104).
TABLE 2. Proportion of replacements versus pop-outs from the
direct-repeat recombination assay
Straina RAD52 genotype nb
Proportion
of LEU2
colonies that
are ura3/
URA3
Frequency of
replacement
events
(105)c
Frequency
of pop-out
events
(105)c
W5977 wt/wt 933 0.17 2.1 0.43
W5978 wt/rad52::HIS5 532 0.32 2.2 1.0
W5979 wt/rad5277-YFP 1291 0.30 2.7 1.2
W5980 wt/rad52284-YFP 1132 0.53 2.3 2.5
a wt, wild-type RAD52 genotype. The full genotypes are listed in Table 1.
b n is the number of LEU2 colonies screened on 5-FOA-containing medium.
c The estimated frequencies of replacements and pop-outs are calculated using
the total recombination frequencies, shown in Fig. 6B, adjusted by the propor-
tions shown in this table.
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Rad52 recruits Rad51 to sites of DNA damage and stimulates
Rad51-mediated DNA strand exchange in vitro. Furthermore,
overexpression of RAD51 suppresses the phenotype of a Rad52
C-terminal truncation (1, 26). Therefore, we tested whether over-
expression of the RAD51 gene could rescue the dominant-nega-
tive -irradiation phenotype seen for rad52284. The seven yeast
strains shown in Fig. 9A were transformed with a plasmid con-
taining the yeast RAD51 gene under the control of a galactose-
inducible promoter (pYES-S10-51; a kind gift from Thomas
Kodadek). This plasmid complements a rad51 null strain in the
presence of galactose (data not shown). Figure 9B shows that the
dominant-negative phenotype of rad52284 is partially rescued
after induction of RAD51 expression (compare the bottom rows
of Fig. 9B, as indicated with a white arrow). This suggests that the
radiation-sensitive phenotype of rad52284 is dependent on its
disruption of Rad51 function(s).
DISCUSSION
Identification of novel RAD52 transcripts from adult mouse
tissue. Here we identify two novel RAD52 transcripts from
adult mouse tissue which are the major alternatively spliced
mRNAs from this gene (Fig. 1). One variant aberrantly splices
the RAD52 mRNA from exon 3 directly to exon 5, skipping
exon 4 (RAD52exon4), while the other variant fails to remove
the short intron 8 (RAD52intron8). These two variant
mRNAs are predicted to encode truncations of the RAD52
peptide and are likely translated in vivo, since both are found
on polyribosomes in the cytoplasm of mouse cells (Fig. 3).
Furthermore, a RAD52 IMAGE clone sequence was identified
that lacks exon 4 (locus id:BC010673, gi:14715025), and se-
quences including RAD52 intron 8 were identified from the
National Center for Biotechnology Information Mouse Uni-
gene Clusters Map (data not shown). However, definitive iden-
tification of these variants using database screening fails, be-
cause many cDNA clone sequences are derived from partially
spliced transcripts. In addition, examination of the sequences
at the intron-exon boundaries of murine RAD52 does not iden-
tify deviations from the canonical splice sites to account for the
alternate splicing. Thus, a solely bioinformatics approach is
inadequate for identifying these novel splice variants, which
requires the rigor of the RT-PCR analysis described here.
Testing the recombination phenotype of variant RAD52
transcripts in cell culture. RAD52exon4 and RAD52intron8
are predicted to encode truncated mouse RAD52 peptides of
80 and 290 amino acids, respectively (Fig. 2). We next tested
the effects of the mouse variants on HDR in mammalian cells
using direct repeats of GFP (Fig. 5A). Expression of the mu-
rine RAD52 variants increase the frequency of gene replace-
ment compared to wild-type mouse RAD52 (Fig. 5), establish-
ing that these variants are capable of altering the DNA repair
phenotype of mammalian cells. Although the increase in HDR
is small, it is consistent with the relatively modest effect on this
type of assay seen when complementing rad52 null cells (43).
Several years ago, Kito et al. speculated that human RAD52
splice variants similar in size to the mouse RAD52exon4 tran-
script might confer a dominant-negative phenotype (16). Here
we demonstrate that C-terminal truncations of RAD52 do in
FIG. 8. (A) Microscopy of a diploid yeast strain containing both
Rad52284-YFP and Rad52-CFP, indicating colocalization. A spon-
taneously occurring Rad52 focus is seen in one cell, and both the YFP
and CFP signals colocalize, as seen in the merged fluorescence image,
indicated by a white arrowhead. The length of the scale bar in the
bottom left of the bright-field image represents 5 m. (B) The pro-
portion of S/G2-phase yeast cells (defined as mononuclear cells with a
bud) that contain at least one Rad52 foci was calculated. The yellow
bars indicate the proportion of cells with Rad52-YFP foci, and the blue
bars indicate the proportion of cells with Rad52-CFP foci (CFP foci
are brighter and more easily counted by microscopy, hence the higher
proportion of CFP foci in the wild-type strain). The error bars indicate the
95% confidence intervals of the binomial proportions. The two diploid
strains, containing novel variant alleles (rad5277-YFP/RAD52-CFP and
rad52284-YFP/RAD52-CFP), have a significantly higher proportion of
wild-type (CFP) foci than the wild-type diploid strain (RAD52-YFP/
RAD52-CFP) (Fishers exact test, P 1.3 105 and 2.3 104, respec-
tively).
TABLE 3. Quantification of Rad52 protein levels
Strain RAD52 genotypea n
Quantification
of CFP signal
mean
fluorescenceb
Quantification
of YFP signal
mean
fluorescenceb
W5937 RAD52-CFP/RAD52-YFP 54 477.5 (
71) 257.2 (
12.5)
W5938 RAD52-CFP/rad5277-YFP 47 504.6 (
40.7) 239.04 (
2.9)
W5939 RAD52-CFP/rad52284-YFP 62 454.4 (
39.9) 264 (
12.5)
a The full genotypes are listed in Table 1. n indicates the number of cells
measured for fluorescence. The amount of CFP is greater than YFP in all cases,
as CFP gives a brighter fluorescence signal. It should be noted that nuclear
fluorescence was measured in all cases, as Rad52 is localized within the nucleus.
However, Rad5277-YFP is localized throughout the cell.
b The mean fluorescence intensity (
standard deviation of the mean) is given
in relative units.
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fact confer a dominant phenotype in mammalian cells by in-
creasing recombination.
Testing the recombination phenotype of variant RAD52
transcripts in yeast. The recombination assays available in
mammalian cells have a number of limitations. We therefore
modeled the splice variants in yeast to allow a further assess-
ment of their role in DNA repair and recombination. A key
advantage of modeling the mouse splice variants in yeast is that
a range of well-characterized assays are available against which
other defined alleles of ScRad52 have previously been tested.
Furthermore, the HDR assays available in yeast are more
diverse and informative than the current mammalian assays.
The two mouse variants, RAD52exon4 and RAD52intron8,
were modeled in the ScRad52 gene (rad5277 and rad52284,
respectively). These alleles are referred to as “splice variant
equivalents,” since they truncate the yeast Rad52 protein at po-
FIG. 9. (A) Two plates of yeast cultures are shown. On each plate seven strains are represented from top to bottom, and six successive 10-fold
dilutions of each strain are plated from left to right. Two plates for each experiment were seeded identically, and one plate was exposed to 200
Gy of -irradiation. The white arrow at the bottom of the irradiated plate shows increased sensitivity for the heterozygous rad52284/RAD52
diploid strain compared to the top strain (wild-type/null), indicating the dominant-negative phenotype of rad52284. The strains in both the top
and bottom of panel B are the same as those described in panel A, except that they each contain plasmid pYES-S10-51 that expresses RAD51 under
the control of a galactose-inducible promoter. The top portion of panel B shows cells grown in the presence of glucose, which does not allow
expression of RAD51. The lower portion of panel B shows galactose-induced cells expressing RAD51. Partial suppression of the -ray sensitivity
of the RAD52-CFP/rad52284-YFP strain, when grown on galactose, is indicated with a white arrow.
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sitions homologous to the mouse variants. The mammalian assay
suggests that expression of the mouse variants elevates repair
from the same or a sister chromosome (Fig. 5), therefore an
equivalent yeast assay was performed. Direct-repeat recombina-
tion in yeast (Fig. 6) shows results similar to those seen in mam-
malian cells (Fig. 5), suggesting that the yeast splice variant equiv-
alents do indeed model their mammalian counterparts. The splice
variant equivalents show additional functional differences, which
were revealed by further analysis of the LEU2 recombination
products from the leu2 direct-repeat assay. For rad5277, the
increased recombination is due to a modest increase in replace-
ment events, whereas for rad52284 the increase is due to pop-
out events (Table 2). In contrast to the increase in leu2 direct-
repeat recombination, the splice variant equivalents dominantly
decrease the frequency of recombination between ade2 hetero-
alleles (Fig. 7). These opposing recombination phenotypes sug-
gest that the variants may bias the HDR pathway away from a
homologous template toward a sister or intrachromatid template.
To probe further the dominant effects of the two splice
variant equivalents, DNA damage sensitivity was tested. While
mammalian rad52 mutant cells exhibit limited DNA damage
sensitivity, yeast rad52 strains are exquisitely sensitive to DNA
damage. Thus, in yeast, sensitivity to DNA damage provides a
simple assay for RAD52 function. As haploid cells, both
rad5277 and rad52284 are sensitive to -irradiation (data
not shown). These results were not surprising, since previous
studies showed that truncations removing more than 200
C-terminal amino acids of ScRad52 render strains as sensitive
as a rad52 null strain to methyl methanesulfonate (MMS), a
DNA-damaging agent (1, 6). In addition, a deletion of the last
175 codons of ScRAD52 confers a defective DSB repair phe-
notype (51).
Since the mammalian variants are coexpressed with full-length
transcripts (Fig. 1B, C, 3, and 4B), diploid strains containing a
splice variant equivalent allele and a wild-type ScRAD52 allele
were tested for -ray sensitivity. The Rad52284 allele is domi-
nant negative, while the Rad5277 allele is not (Fig. 9A). Previ-
ous work has shown that overexpression of two ScRad52 C-ter-
minal truncations confers a dominant-negative phenotype for
sensitivity to MMS (26), suggesting that N-terminal Rad52 pep-
tides are capable of disrupting the DNA repair ability of the
full-length protein. Interestingly, structural analysis of both the
full-length human RAD52 protein and an N-terminal fragment
reveals a multimeric complex with RAD52 monomers arranged
in a ring configuration (15, 40, 44). Therefore, it is likely that the
RAD52intron8 variant is incorporated into the ring and dis-
rupts its function. This view is supported by our finding that
Rad52284 and wild-type Rad52 colocalize in foci (Fig. 8A). In
addition, increased levels of wild-type Rad52 foci caused by the
splice variant equivalents may indicate increased DNA damage.
However, it is unclear how increased damage could cause a spe-
cific preference for repair from the same or a sister chromosome.
Indeed, DNA damage elevates repair from both sister and ho-
mologous chromosomes (13). In addition, elevated Rad52 foci
levels in yeast mutants typically indicate delayed or impaired
repair processes.
Disruption of the Rad52-Rad51 interaction and its effects on
recombination. C-terminal truncations of Rad52 are known to
disrupt its interaction with Rad51, thus impairing the forma-
tion of Rad51 filaments (19, 26, 37, 39). Such Rad52 C-termi-
nal truncation mutants are complemented by overexpression of
RAD51 (1, 26). Furthermore, disruption of the Rad52-Rad51
interaction in both yeast and mammalian cells channels recom-
bination intermediates to Rad51-independent repair pathways,
such as single-strand annealing (SSA) or break-induced repli-
cation (33, 43, 51). The dominant recombination phenotype
exhibited by the splice variants may be due to disruption of this
Rad52-Rad51 interaction. Indeed, we find that the dominant-
negative -ray sensitive phenotype of Rad52284 is partially
rescued by overexpression of the RAD51 gene (Fig. 9B). In
addition, the rad52284 allele increases pop-out recombina-
tion between leu2 direct repeats that likely occurs by SSA.
Together, these data support the notion that Rad51-dependent
pathways have been disrupted.
On the surface, expression of all the variants results in in-
creased direct-repeat recombination in both mammalian cells
and yeast. However, further analysis of the recombinants in
yeast reveals some differences. For example, the shorter
rad5277 variant increases the frequency of gene conversion
events in contrast to rad52284, which increases pop-out
events. In addition, Rad5277 does not colocalize with wild-
type Rad52 in DNA repair foci or cause a dominant-negative
-ray sensitivity phenotype, like Rad52284 does. However,
despite these differences, both yeast variants increase wild-type
Rad52 focus levels and increase direct-repeat recombination.
Thus, we conclude that these variants may disrupt HDR in a
similar way and represent a new phenotype for rad52 N-ter-
minal mutants (28).
RAD52 variants favor sister chromatid repair. We show that
the RAD52 splice variants dominantly increase the frequency
of direct-repeat recombination from the same or a sister chro-
mosome in both mammalian cells and yeast. In yeast, where we
are able to easily measure the frequency of recombination
between heteroalleles on homologous chromosomes, the splice
variant equivalents lower the frequency of recombination.
Rad51-independent repair pathways are also required for in-
terchromosomal but not intrachromosomal repair in yeast (2).
Therefore, it is possible that expression of the RAD52 splice
variants in mammalian cells inhibits RAD51-dependent inter-
chromosomal repair of spontaneous lesions, consequently forc-
ing them to be repaired from the sister chromatid. Perhaps
expression of RAD52intron8 inhibits the activity of RAD51,
impairing the homology search ability of the repair complex.
This, in turn, may favor the repair of DSBs using the sister
chromatid template, which is tethered by cohesin, rather than
searching for a homolog (18, 34). Similarly, depletion of p53
also favors intrachromosomal or sister chromatid repair (53),
perhaps mediated through the inhibition of RAD51. Recently,
differential expression of splice variants of p53 was found in
human breast tumors compared to normal breast tissue (7).
Similarly, the differential expression of the RAD52 splice vari-
ants in the various cell types, shown in Fig. SA of the supple-
mental material, may control selective preferences for recom-
bination in different adult tissues.
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